Article
Polygenic Embryo Screening: High Approval Despite Substantial Concerns from the U.S. Public
2023-10-14
Abstract excerpt
Polygenic embryo screening (PES) is a novel – yet commercially available – technology that can compute genetic likelihood estimates of polygenic conditions (e.g., diabetes, depression) and traits (e.g., height, cognitive ability) in embryos. Patients undergoing in vitro fertilization (IVF) can use these polygenic scores to select which embryos to transfer for implantation with the goal of having a child. We conduc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bb951554-5c04-5875-a4da-e4e2f6857d54
- DOI
- 10.1101/2023.10.13.23297022
